Otitis media and mastoiditis due to Mycobacterium fortuitum: Case report, review of four cases, and a cautionary note

Clinical Infectious Diseases

Volumn 22, Issue 6, 1996, Pages 1105-1106

  Plemmons, Robert M ^a   McAllister, C Kenneth ^a   Liening, Douglas A ^a   Garces, Maria C ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CLARITHROMYCIN; COTRIMOXAZOLE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; FEMALE; HUMAN; INFECTION RISK; MALE; MASTOIDITIS; MYCOBACTERIUM FORTUITUM; OTITIS MEDIA; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029772368     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.6.1105     Document Type: Article

References (10)

1. Lowry PW, Jarvis WR, Oberle AD, et al. Mycobacterium chelonae causing otitis media in an ear-nose-and-throat practice. N Engl J Med 1988;319:978-82.
2. Moerman J, Dierick J, Mestdagh J, Boedts D, Van Cauwenberge P. Mastoiditis caused by atypical mycobacteria. Int J Pediatr Otorhinolaryngol 1993;28:69-76.
3. Franklin DJ, Starke JR, Brady MT, Brown BA, Wallace RJ Jr. Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity? Am J Otol 1994;15:313-20.
4. Nylen O, Alestig K, Fasth A, et al. Infections of the ear with nontuberculous mycobacteria in three children. Pediatr Infect Dis J 1994;13:653-6.
5. Austin WK, Lockey MW. Mycobacterium fortuitum mastoiditis. Arch Otolaryngol 1976;102:558-60.
6. Neitch SM, Sydnor JB, Schleupner CJ. Mycobacterium fortuitum as a cause of mastoiditis and wound infection. Arch Otolaryngol 1982;108:11-4.
7. Dalovisio JR, Pankey GA, Wallace RJ, Jones DB. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis 1981;3:1068-74.
8. Sanders WE Jr, Hartwig EC, Schneider NJ, Cacciatore R, Valdez H. Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents. Antimicrob Agents Chemother 1977;12:295-7.
9. McFarland EJ, Kuritzkes DR. Clinical features and treatment of infection due to Mycobacterium fortuitum/chelonae complex. In: Remington JS, Swartz MN, eds. Current clinical topics in infectious diseases. Boston: Blackwell Scientific Publications, 1993:188-202.
10. Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis 1985;152:500-14.